Financial reports
ARS
2023 FY
Annual report to shareholders
15 Apr 24
10-K
2023 FY
Annual report
21 Feb 24
10-Q
2023 Q3
Quarterly report
25 Oct 23
10-Q
2023 Q2
Quarterly report
26 Jul 23
ARS
2022 FY
Annual report to shareholders
25 May 23
10-K/A
2022 FY
Annual report (amended)
26 Apr 23
10-Q
2023 Q1
Quarterly report
26 Apr 23
10-K
2022 FY
Annual report
16 Feb 23
10-Q
2022 Q3
Quarterly report
2 Nov 22
10-Q
2022 Q2
Quarterly report
27 Jul 22
Current reports
8-K
Regulation FD Disclosure
9 Apr 24
8-K
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
7 Mar 24
8-K
Results of Operations and Financial Condition
15 Feb 24
8-K
Departure of Directors or Certain Officers
5 Feb 24
8-K
Regulation FD Disclosure
8 Jan 24
8-K
Alkermes plc Announces Agreement to Sell Athlone, Ireland Facility to Novo Nordisk
14 Dec 23
8-K
Departure of Directors or Certain Officers
8 Dec 23
8-K
Alkermes Completes Separation of Oncology Business
15 Nov 23
8-K
Alkermes Announces Effectiveness of Mural Oncology Form 10 Registration Statement
31 Oct 23
8-K
Other Events
27 Oct 23
Registration and prospectus
S-8
Registration of securities for employees
26 Jul 23
S-8
Registration of securities for employees
27 Jul 22
S-8
Registration of securities for employees
28 Jul 21
S-8
Registration of securities for employees
29 Jul 20
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jul 20
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jul 20
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jul 20
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jul 20
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jul 20
S-8
Registration of securities for employees
25 Jul 19
Proxies
DEFA14A
Additional proxy soliciting materials
15 Apr 24
DEF 14A
Definitive proxy
15 Apr 24
PRE 14A
Preliminary proxy
5 Apr 24
DFAN14A
Additional proxy materials by non-management
28 Jun 23
DFAN14A
Additional proxy materials by non-management
28 Jun 23
DEFA14A
Additional proxy soliciting materials
26 Jun 23
DFAN14A
Additional proxy materials by non-management
26 Jun 23
DEFA14A
Additional proxy soliciting materials
26 Jun 23
DEFA14A
Additional proxy soliciting materials
26 Jun 23
DFAN14A
Additional proxy materials by non-management
22 Jun 23
Other
UPLOAD
Letter from SEC
19 May 23
CORRESP
Correspondence with SEC
19 May 23
UPLOAD
Letter from SEC
16 May 23
CT ORDER
Confidential treatment order
19 May 20
SEC STAFF
SEC staff action: Order
27 Feb 20
SEC STAFF
SEC staff action: Order
10 Feb 20
CT ORDER
Confidential treatment order
4 Dec 19
CT ORDER
Confidential treatment order
14 Mar 19
CT ORDER
Confidential treatment order
29 Nov 18
CT ORDER
Confidential treatment order
30 May 18
Ownership
4
Nancy Lurker
12 Apr 24
144
Notice of proposed sale of securities
18 Mar 24
4
Christian Todd Nichols
18 Mar 24
3
Nancy Lurker
15 Mar 24
4
Christian Todd Nichols
27 Feb 24
4
Samuel Joseph Parisi
27 Feb 24
4
Iain Michael Brown
27 Feb 24
4
David Joseph Gaffin
27 Feb 24
4
MICHAEL J LANDINE
27 Feb 24
4
Blair Curtis Jackson
27 Feb 24